NCT00001958View on ClinicalTrials.gov

Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 1999

Study Completion Date

February 28, 2002

Conditions
Beta ThalassemiaHemoglobinopathy
Interventions
DRUG

Hydroxyurea

Trial Locations (1)

20892

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00001958 - Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia) | Biotech Hunter | Biotech Hunter